Trial Profile
An Open-label Study of the Efficacy and Safety of Re-treatments With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Methylprednisolone
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 26 Mar 2014 New trial record